64 results on '"Pharmacogenomics -- Reports"'
Search Results
2. Reports on Pharmacogenomics Findings from Agency for Medicinal Products & Medical Devices Provide New Insights (Implementation of pharmacogenomics in product information)
3. Global Proteomics Market Study by Product, Application, End-user and Geography 2019-2026 - ResearchAndMarkets.com
4. Findings from Department of Cardiology Broadens Understanding of Pharmacogenomics (Prioritizing rs7294 as a mirSNP contributing to warfarin dosing variability)
5. University of Michigan Reports Findings in Pharmacogenomics (Challenges to assess substrate-dependent allelic effects in CYP450 enzymes and the potential clinical implications)
6. Study Data from Al-Zaytoonah University Provide New Insights into Pharmacogenomics and Personalized Medicine (Knowledge And Attitudes Of Pharmacy Students Towards Pharmacogenomics Among Universities In Jordan And West Bank Of Palestine)
7. Reports Outline Pharmacogenomics Findings from Tohoku University (Construction of Full-length Japanese Reference Panel of Class I Hla Genes With Single-molecule, Real-time Sequencing)
8. State University of New York Reports Findings in Pharmacogenomics (RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms)
9. New Personalized Medicine Findings Reported from University of Science and Technology (A novel approach for drug response prediction in cancer cell lines via network representation learning)
10. New Pharmacogenomics Study Findings Have Been Reported by Researchers at University of Belgrade (Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia)
11. Studies in the Area of Pharmacogenomics Reported from Agency for Science, Technology and Research (Applications of pharmacogenomics in regulatory science: a product life cycle review)
12. New Chemotherapy Study Results from University of California Described (Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity)
13. New Pharmacogenomics Findings from Harvard School of Medicine Discussed (Pharmacogenomic Primer for the Pediatrician-What Is Really Important?)
14. Reports Outline Pharmacogenomics Findings from Central South University (NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome)
15. Findings from Division of Molecular Genetics Broaden Understanding of Mutagenesis (Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance)
16. Studies from T. Cokelaer et al in the Area of Pharmacogenomics Described (GDSCTools for mining pharmacogenomic interactions in cancer)
17. Findings from Rehabilitation Research Center in the Area of Pharmacogenomics Reported [Na(V)1.7 as a Pharmacogenomic Target for Pain: Moving Toward Precision Medicine]
18. Findings from Networked Biomedical Research Center - Hepatic and Digestive Diseases in the Area of Tumor Necrosis Factors Reported (New polymorphisms associated with response to anti-TNF drugs in patients with moderate-to-severe plaque psoriasis)
19. Findings from Radboud University Medical Center Provide New Insights into Biologics (A systematic review of pharmacogenetic studies on the response to biologics in patients with psoriasis)
20. Reports on Breast Cancer Findings from University Hospital Provide New Insights (Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by ...)
21. Findings on Pharmacogenomics Described by Researchers at National Cancer Institute (Updating the landscape of direct-to-consumer pharmacogenomic testing)
22. Investigators at H. Lee Moffitt Cancer Center and Research Institute Have Reported New Data on Pharmacogenomics (Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate ...)
23. Findings in Public Health Reported from University of Patras (Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics)
24. New Parkinson's Disease Study Findings Have Been Reported by Researchers at University of Alabama at Birmingham (The emerging science of precision medicine and pharmacogenomics for Parkinson's disease)
25. Reports Outline Cancer Research Findings from Ontario Institute for Cancer Research (Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy)
26. Implementing Preemptive Pharmacogenomic Testing for Colorectal Cancer Patients in a Community Oncology Clinic
27. New Pharmacogenomics Study Findings Reported from Mayo Clinic (Incorporation of Herbal Supplements into a Pharmacogenomic Medication Therapy Management Practice)
28. New Findings from Northwestern University in the Area of Chronic Disease Reported (Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice)
29. Reports on Alcoholism Findings from Democritus University of Thrace Provide New Insights (Personalized Medicine of Alcohol Addiction: Pharmacogenomics and beyond)
30. Reports Outline Vasculitis Findings from Ohio State University (The Pharmacogenomic Association of Fc gamma Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic ...)
31. New Thalassemia Study Findings Reported from Ain Shams University (Klf10 Gene, a Secondary Modifier and a Pharmacogenomic Biomarker of Hydroxyurea Treatment Among Patients With Hemoglobinopathies)
32. New Pharmacogenomics Study Findings Recently Were Reported by Researchers at McGill University (Addressing ethical challenges at the intersection of pharmacogenomics and primary care using deliberative consultations)
33. Findings from Montreal Heart Institute in Heart Failure Reported (Pharmacogenomics of heart failure: a systematic review)
34. New Findings from G. Ragia and Co-Researchers in the Area of Pharmacogenomics Described (A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial)
35. New Findings on Sickle Cell Anemia Described by Investigators at University of Cape Town (An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine)
36. Recent Findings in Alzheimer Disease Described by Researchers from McGill University (Butyrylcholinesterase K and Apolipoprotein E-epsilon 4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil ...)
37. New Findings from Central South University in the Area of Drug Resistance Reported (The pharmacogenomics of drug resistance to protein kinase inhibitors)
38. Findings from Cancer Institute Provides New Data about Pharmacogenomics (Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity)
39. Findings from Baylor University College of Medicine in the Area of Pharmacogenomics Described [The alpha-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals]
40. Data on Pharmacogenomics Reported by Researchers at University of Messina (Genomic Variations Affecting Biological Effects of Statins)
41. Researchers at Erasmus University Medical Center Report New Data on Pharmacogenetics (Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics)
42. Recent Findings from University of Michigan Provide New Insights into Breast Cancer (Pharmacogenetic Predictors of Response)
43. Investigators at Fudan University Release New Data on Pharmacogenomics (Tag SNPs for HLA-B alleles that are associated with drug response and disease risk in the Chinese Han population)
44. New Pharmacogenomics Findings from A. Vivot and Co-Researchers Described (Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs)
45. New Findings on Pharmacogenomics Discussed by Researchers at University of Texas Southwestern Medical Center (Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B)
46. New Findings Reported from Seoul National University Describe Advances in Pharmacogenomics (Analysis of pharmacogenomic variants associated with population differentiation)
47. Technion-Israel Institute of Technology Reports Findings in Type 2 Diabetes (Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability)
48. Reports from National Cancer Institute Add New Data to Findings in Colon Cancer (Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy)
49. Reports Summarize Blood Research Study Results from University of Turin (Efavirenz pharmacogenetics in a cohort of Italian patients)
50. Researchers from Tajen University Report Recent Findings in Diabetes (Drug Metabolizing Enzymes in Type II Diabetes and their Pharmacogenetics During Therapy of Anti-Diabetes Drugs)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.